Author

B. Sahaf

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Banuelos· 1 shared A. Delaidelli· 1 shared A. Leruste· 1 shared B. J. McIntosh· 1 shared C. L. Mackall· 1 shared C. W. Mount· 1 shared D. M. Marquez· 1 shared E. Meyer· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Banuelos

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Engineered CD47 protects T cells for enhanced antitumor immunity

S. A. Yamada-Hunter, J. Theruvath, B. J. McIntosh, K. A. Freitas, M. T. Radosevich, A. Leruste, S. Dhingra, N. Martinez-Velez, P. Xu, A. Delaidelli, M. H. Desai, Z. Good, L. Labanieh, C. W. Mount, Y. Chen, , C. L. Mackall

This paper engineers a CD47 variant to protect T cells from macrophage clearance, enhancing antitumor efficacy by combining T cell and macrophage activation.

bioRxiv · Jun 20, 2023 · PreprintBioengineering

Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy

F. J. Hartmann, J. Babdor, P. F. Gherardini, E.-A. D. Amir, K. Jones, B. Sahaf, D. M. Marquez, P. Krutzik, E. O'Donnell, N. Sigal, H. T. Maecker, E. Meyer, M. H. Spitzer, S. C. Bendall

The paper presents a mass cytometry workflow for standardized immune monitoring in immunotherapy trials, identifying immune cell signatures and validating its robustness across samples and centers.

bioRxiv · Dec 13, 2018Immunology